Therapeutic biology: Checkpoint pathway activation therapy, HIV Tat, and transkingdom RNA interference

被引:6
作者
Li, Chiang J. [1 ]
机构
[1] ArQule Inc, ArQule Biomed Inst, Boston, MA 02062 USA
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA
关键词
D O I
10.1002/jcp.20817
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Therapeutic biology is an exciting new frontier in the post-genomic era with the mission to better human health. The explosive increase in the understanding of molecular and regulatory biology has enabled the identification of a plethora of potential targets and pathways for the discovery of new medicines. Conversely, molecularly based therapeutic intervention of biological aberrations in human diseases offers a test of the depth of our understanding of biology. This article discusses three examples of therapeutic biology research. The first concerns the treatment of cancer by activating genome surveillance circuitry, namely checkpoint-pathway activation therapy. The second example is the identification of the HIV Tat protein as both a cause of immune cell activation and apoptosis, and as a vaccine candidate against HIV infection. The third example describes transkingdom RNA interference and its application in the investigational and therapeutic silencing of disease genes.
引用
收藏
页码:695 / 700
页数:6
相关论文
共 65 条
[1]   The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals [J].
Addo, MM ;
Altfeld, M ;
Rosenberg, ES ;
Eldridge, RL ;
Philips, MN ;
Habeeb, K ;
Khatri, A ;
Brander, C ;
Robbins, GK ;
Mazzara, GP ;
Goulder, PJR ;
Walker, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1781-1786
[2]  
Ahn JY, 2000, CANCER RES, V60, P5934
[3]   Chk1 and Chk2 kinases in checkpoint control and cancer [J].
Bartek, J ;
Lukas, J .
CANCER CELL, 2003, 3 (05) :421-429
[4]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[5]   Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks [J].
Bekker-Jensen, S ;
Lukas, C ;
Kitagawa, R ;
Melander, F ;
Kastan, MB ;
Bartek, J ;
Lukas, J .
JOURNAL OF CELL BIOLOGY, 2006, 173 (02) :195-206
[6]   Inhibition of respiratory viruses by nasally administered siRNA [J].
Bitko, V ;
Musiyenko, A ;
Shulyayeva, O ;
Barik, S .
NATURE MEDICINE, 2005, 11 (01) :50-55
[7]   Cell senescence and hypermitogenic arrest [J].
Blagosklonny, MV .
EMBO REPORTS, 2003, 4 (04) :358-362
[8]   Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors [J].
Campisi, J .
CELL, 2005, 120 (04) :513-522
[9]   Recent advances in the development of HIV-1 Tat-based Vaccines [J].
Caputo, A ;
Gavioli, R ;
Ensoli, B .
CURRENT HIV RESEARCH, 2004, 2 (04) :357-376
[10]   Timeline - Chemotherapy and the war on cancer [J].
Chabner, BA ;
Roberts, TG .
NATURE REVIEWS CANCER, 2005, 5 (01) :65-72